Insiders Mesoblast Limited

Equities

MSB

AU000000MSB8

Delayed Australian S.E. Other stock markets 02:10:06 2024-05-08 am EDT			5-day change	1st Jan Change
1.13 ^AUD	-3.83%		+2.73%	+264.52%

Apr. 01	ADRs End Higher; Connect Biopharma Climbs 26%	DJ
Mar. 28	ADRs End Lower; NuCana Slides 15%	DJ

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pre-Holiday Data Slew Awaited as Exchange-Traded Funds, Equity Futures Rise Pre-Bell Wednesday	Nov. 22	MT
Mesoblast Limited Announces Cessation of Michael Spooner as Director	23-10-03	CI
Jane Bell AM Appointed Chair of Mesoblast Audit and Risk Committee	23-09-26	CI
Mesoblast Limited Appoints Philip R. Krause, Member of the Board of Directors, to Formal Strategic Advisory Role	23-06-04	CI
Mesoblast Limited Announces Board Changes	22-08-17	CI
Mesoblast Limited Announces Executive Changes	22-04-06	CI
Mesoblast Limited Appoints Philip R. Krause to its Board of Directors	22-03-23	CI
Donal O'Dwyer Retires from the Board of Mesoblast Limited	22-02-24	CI
Mesoblast Appoints Chief Medical Officer	22-02-02	MT
Mesoblast Names New Chief Medical Officer	22-02-01	MT
Mesoblast Limited Appoints Eric Rose as Chief Medical Officer	22-02-01	CI
Mesoblast Limited Appoints Philip J. Facchina to Its Board of Directors	21-03-28	CI
Mesoblast Limited Announces the Appointment of Dagmar Rosa-Bjorkeson to the Role of Chief Operating Officer, Based in New York	20-07-24	CI
US FDA Agrees to the Selection of Mesoblast Limited's Ryoncil as the Commercial Name for its Lead Allogeneic Cell Therapy Remestemcel-L in the Treatment of Pediatric Steroid-Refractory Acute Graft Versus Host Disease	20-01-15	CI
Mesoblast Limited Announces Appointment of Joint Company Secretary	19-10-28	CI
Mesoblast Limited Appoints Fred Grossman as Chief Medical Officer	19-08-11	CI
Mesoblast Limited Announces the Cessation of Brian Jamieson as Director Effective from 31 March 2019	19-04-05	CI
U.S. Healthcare Leader Joseph R. Swedish Appointed Mesoblast Chairman	19-03-22	GL
Mesoblast Limited Announces Board Changes	19-03-21	CI
Mesoblast Limited Appoints Eric Strati as Senior Vice President, Commercial	18-12-19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Mesoblast Limited

Equities

MSB

AU000000MSB8

Insiders

Filters